根据最终合并协议,Viewpoint的每一股已发行和流通股份将转换为获得Isoray 3.3212股的权利。Viewpoint股东将拥有Isoray完全稀释的流通股49%的股份。
$华海药业(SH600521)$ $华东医药(SZ000963...查看全文
$IsoRay, Inc.(ISR)$ 8-K - Current report Filed: 2018-05-21 AccNo: 0001437749-18-010424 Size: 186 KBItem 1.01: Entry into a Material Definitive AgreementItem 9.01: Financial Statements and Exhibits 网页链接
$IsoRay, Inc.(ISR)$ 8-K - Current report Filed: 2018-05-11 AccNo: 0001437749-18-009530 Size: 30 KBItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接
$IsoRay, Inc.(ISR)$ 8-K - Current report Filed: 2018-05-08 AccNo: 0001437749-18-009044 Size: 214 KBItem 1.01: Entry into a Material Definitive AgreementItem 9.01: Financial Statements and Exhibits 网页链接
$IsoRay, Inc.(ISR)$ 424B5 - Prospectus [Rule 424(b)(5)] Filed: 2018-05-08 AccNo: 0001437749-18-009043 Size: 323 KB 网页链接
$IsoRay, Inc.(ISR)$ 8-K - Current report Filed: 2018-05-08 AccNo: 0001437749-18-009044 Size: 214 KBItem 1.01: Entry into a Material Definitive AgreementItem 9.01: Financial Statements and Exhibits 网页链接
$IsoRay, Inc.(ISR)$ 424B5 - Prospectus [Rule 424(b)(5)] Filed: 2018-05-08 AccNo: 0001437749-18-009043 Size: 323 KB 网页链接
$IsoRay, Inc.(ISR)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2018-05-04 AccNo: 0001437749-18-008689 Size: 3 MB 网页链接
$IsoRay, Inc.(ISR)$ 8-K - Current report Filed: 2018-05-03 AccNo: 0001437749-18-008541 Size: 192 KBItem 2.02: Results of Operations and Financial ConditionItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接
$IsoRay, Inc.(ISR)$ 8-K - Current report Filed: 2018-04-20 AccNo: 0001437749-18-007314 Size: 44 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接
$IsoRay, Inc.(ISR)$ 内部交易: 2018-03-14,Director,Vitale Philip J ,买入,10000普通股, $0.44